These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2419226)

  • 1. The effect of different doses of 32P in the treatment of primary thrombocytosis.
    Randi ML; Fabris F; Varotto L; Peverelli P; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):950-6. PubMed ID: 2419226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiophosphorus (32P) treatment of bone marrow disorders in dogs: 11 cases (1970-1987).
    Smith M; Turrel JM
    J Am Vet Med Assoc; 1989 Jan; 194(1):98-102. PubMed ID: 2914806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential thrombocythemia: response during first year of therapy with melphalan and radioactive phosphorus: a polycythemia Vera Study Group report.
    Murphy S; Rosenthal DS; Weinfeld A; Briere J; Faguet GB; Knospe WH; Landaw SA; Laszlo J; Pisciotta AV; Tartaglia AP
    Cancer Treat Rep; 1982 Jul; 66(7):1495-500. PubMed ID: 7046930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-interferon in polycythemia vera and essential thrombocythemia.
    Turri D; Mitra ME; Di Trapani R; Lipari MG; Perricone R; Cajozzo A
    Haematologica; 1991; 76(1):75-7. PubMed ID: 2055565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera].
    Tesselaar ME; Wijermans PW; Metsaars JA; Gerrits WB; Haak HL
    Ned Tijdschr Geneeskd; 1996 Sep; 140(38):1900-2. PubMed ID: 8927166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of 32 phosphorus (32P) in the treatment of polycythemia vera.
    Parmentier C; Gardet P
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of 32P in the management of haematological disorders.
    Bareford D
    Nucl Med Commun; 1991 Sep; 12(9):751-3. PubMed ID: 1945185
    [No Abstract]   [Full Text] [Related]  

  • 9. Busulfan versus 32P in polycythaemia vera.
    Zittoun R
    Drugs Exp Clin Res; 1986; 12(1-3):283-5. PubMed ID: 3525077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematological complications in polycythaemia vera and thrombocythaemia patients treated with radiophosphorus (32P).
    Randi ML; Fabris F; Varotto L; Rossi C; Macri C; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):461-7. PubMed ID: 1703118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
    Michiels JJ; Berneman Z; Schroyens W; van Urk H
    Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of polycythemia with 32P].
    Vlakhov N; Parusheva D; Kostov K
    Med Radiol (Mosk); 1986 Mar; 31(3):55. PubMed ID: 3959801
    [No Abstract]   [Full Text] [Related]  

  • 14. Low incidence of familial occurrence of thrombocythaemia and/or thrombocytosis.
    Randi ML; Fabris F; Visentin I; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):695-9. PubMed ID: 2465250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon therapy in essential thrombocythemia].
    Seewann HL
    Wien Med Wochenschr; 1993; 143(16-17):420-4. PubMed ID: 8273365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on polycythemia vera turning into acute or chronic granulocytic leukemia during treatment with radioactive phosphorus 32P.
    Krańik W
    Pol Med Sci Hist Bull (1973); 1975; 15(4):447-52. PubMed ID: 1063385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of 259 patients with primary proliferative polycythaemia (PPP) and idiopathic thrombocythaemia (IT) treated in a regional nuclear medicine department with phosphorus-32--a 15 year review.
    Balan KK; Critchley M
    Br J Radiol; 1997 Nov; 70(839):1169-73. PubMed ID: 9536909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential thrombocythemia following polycythemia vera: an unusual sequence.
    Randi ML; Barbone E; Zerbinati P; Soini B; Rossi C; Girolami A
    J Med; 1996; 27(5-6):363-8. PubMed ID: 9151204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic changes in platelet-large cell ratio, lactate dehydrogenase and C-reactive protein in thrombocytosis-related diseases.
    Kabutomori O; Kanakura Y; Iwatani Y
    Acta Haematol; 2007; 118(2):84-7. PubMed ID: 17622783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L. Gruppo Italiano Malattie Mieloproliferative Croniche(GIMMC).
    Sacchi S; Vinci G; Gugliotta L; Rupoli S; Gargantini L; Martinelli V; Baravelli S; Lazzarino M; Finazzi G
    Haematologica; 2000 May; 85(5):492-5. PubMed ID: 10800165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.